Impact of Blood Glucose Self-Monitoring Errors on Glucose Variability, Risk for Hypoglycemia, and Average Glucose Control in Type 1 Diabetes: An In Silico Study
Open accessAbstract
Background: Clinical trials assessing the impact of errors in self-monitoring of blood glucose (SMBG) on the quality of glycemic control in diabetes are inherently difficult to execute. Consequently, the objectives of this study were to employ realistic computer simulation based on a validated model of the human metabolic system and to provide potentially valuable information about the relationships among SMBG errors, risk for hypoglycemia, glucose variability, and long-term glycemic control. Methods: Sixteen thousand computer simulation trials were conducted using 100 simulated adults with type 1 diabetes. Each simulated subject was used in four simulation experiments aiming to assess the impact of SMBG errors on detection of hypoglycemia (experiment 1), risk for hypoglycemia (experiment 2), glucose variability (experiment 3), and long-term average glucose control, i.e., estimated hemoglobin A1c (HbA1c)(experiment 4). Each experiment was repeated 10 times at each of four increasing levels of SMBG errors: 5, 10, 15, and 20% deviation from the true blood glucose value. Results: When the permitted SMBG error increased from 0 to 5–10% to 15–20%—the current level allowed by International Organization for Standardization 15197—(1) the probability for missing blood glucose readings of 60 mg/dl increased from 0 to 0–1% to 3.5–10%; (2) the incidence of hypoglycemia, defined as reference blood glucose ≤70 mg/dl, changed from 0 to 0–0% to 0.1–5.5%; (3) glucose variability increased as well, as indicated by control variability grid analysis; and (4) the incidence of hypoglycemia increased from 15.0 to 15.2–18.8% to 22–25.6%. When compensating for this increase, glycemic control deteriorated with HbA1c increasing gradually from 7.00 to 7.01–7.12% to 7.26–7.40%. Conclusions: A number of parameters of glycemic control deteriorated substantially with the increase of permitted SMBG errors, as revealed by a series of computer simulations (e.g., in silico) experiments. A threshold effect apparent between 10 and 15% permitted SMBG error for most parameters, except for HbA1c, which appeared to be increasing relatively linearly with increasing SMBG error above 10%.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The probability to measure blood glucose monitoring system results >70 mg/dL with a 'true' glucose concentration of 60 mg/dL increased 10-fold when the allowed range within which 95% of results were found is increased from ±7 mg/dL or ±10% to ±15 mg/dL or ±20%.
“They found that the probability to measure BGMS results >70 mg/dL (3.88 mmol/L) with a “true” glucose concentration of 60 mg/dL (3.33 mmol/L) increased 10-fold when the allowed range within which 95% of results were found is increased from ±7 mg/dL (0.39 mmol/L) or ±10% (for glucose concentrations <75 mg/dL (4.16 mmol/L) or ≥75 mg/dL (4.16 mmol/L), respectively) to ±15 mg/dL (0.83 mmol/L) or ±20%.”
From System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015 (2020) · cites this paper as [26]
Increasingly inaccurate blood glucose monitoring system results lead to higher glycemic variability when pre-meal and insulin correction boluses were integrated in the model.
“Furthermore, increasingly inaccurate BGMS results were found to lead to higher glycemic variability when pre-meal and insulin correction boluses were integrated in the model.”
From System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015 (2020) · cites this paper as [26]
Cites
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955 · see citing works
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794 · see citing works
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511 · see citing works
Self-citationEffect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393 · see citing works
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391 · see citing works
Hypoglycemia: The Limiting Factor in the Management of IDDM
Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.11.1378 · Cited by 307 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Exercise management in type 1 diabetes: a consensus statement
Riddell, M. C., Gallen, I. W., Smart, C. E., Taplin, C. E., Adolfsson, P., Lumb, A. N., Kowalski, A., Rabasa-Lhoret, R., McCrimmon, R. J., Hume, C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30014-1 · Cited by 903 · see citing works
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234 · see citing works
Self-citationMeasures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
Freckmann, G., Pleus, S., Grady, M., Setford, S., & Levy, B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818812062 · Cited by 202 · see citing works
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1960 · Cited by 144 · see citing works
Self-citationInterferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge
Erbach, M., Freckmann, G., Hinzmann, R., Kulzer, B., Ziegler, R., Heinemann, L., & Schnell, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816641433 · Cited by 115 · see citing works
Pleus, S., Baumstark, A., Jendrike, N., Mende, J., Link, M., Zschornack, E., Haug, C., & Freckmann, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001067 · Cited by 63 · see citing works
Performance of Cleared Blood Glucose Monitors
Klonoff, D. C., & Prahalad, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815584797 · Cited by 59 · see citing works
Pleus, S., Freckmann, G., Schauer, S., Heinemann, L., Ziegler, R., Ji, L., Mohan, V., Calliari, L. E., & Hinzmann, R. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01254-8 · Cited by 55 · see citing works
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37 · see citing works
Klonoff, D. C., & Reyes, J. S. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700432 · Cited by 29 · see citing works
Baumstark, A., Jendrike, N., Pleus, S., Haug, C., & Freckmann, G. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0408 · Cited by 22 · see citing works
Clinical impact of blood glucose monitoring accuracy: an in-silico study
Campos-Náñez, E., Fortwaengler, K., & Breton, M. D. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817710474 · Cited by 22 · see citing works
Self-citationPfützner, A., Jensch, H., Cardinal, C., Srikanthamoorthy, G., Riehn, E., & Thomé, N. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221095573 · Cited by 20 · see citing works
The financial impact of inaccurate blood glucose monitoring systems
Fortwaengler, K., Campos-Náñez, E., Parkin, C. G., & Breton, M. D. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817731423 · Cited by 17 · see citing works
Self-citationMcQueen, R. B., Breton, M. D., Ott, M., Koa, H., Beamer, B., & Campbell, J. D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815599551 · Cited by 17 · see citing works
Self-citationJendrike, N., Baumstark, A., Pleus, S., Liebing, C., Beer, A., Flacke, F., Haug, C., & Freckmann, G. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0391 · Cited by 17 · see citing works
Karon, B. S., Meeusen, J. W., & Bryant, S. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815602099 · Cited by 16 · see citing works
Yu-Fei, W., Wei-Ping, J., Ming-Hsun, W., Miao-O, C., Ming-Chang, H., Chi-Pin, W., & Ming-Shih, L. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817705143 · Cited by 15 · see citing works
McQueen, R. B., Breton, M. D., Craig, J., Holmes, H., Whittington, M. D., Ott, M. A., & Campbell, J. D. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818769098 · Cited by 12 · see citing works
Self-citationHinzmann, R., Militz, D., Zima, T., Špaček, M., Storm, H., Chapanduka, Z., & Hauss, O. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108860 · Cited by 2 · see citing works
- Authors
- Breton, M. D., & Kovatchev, B. P.
- Affiliations
- University of Virginia (US)
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2010-05
- Volume
- 4
- Issue
- 3
- Pages
- 562-570
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC2901032
- OpenAlex
- W2124281539
- Cited by
- 103
- References
- 6
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2022: 6 · 2021: 6 · 2020: 9 · 2019: 4 · 2018: 13 · 2017: 12 · 2016: 6 · 2015: 12 · 2014: 9 · 2013: 9 · 2012: 4
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk051562-23)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK 51562, R01-DK-051562)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › Emergency Medical Services › Patient Safety and Medication Errors
- Keywords
- self-monitoring of blood glucose, type 1 diabetes, hypoglycemia risk, glycemic variability, glycemic control, HbA1c, computer simulation, hypoglycemia detection
- MeSH terms
- Blood Glucose, Computer Simulation, Diabetes Mellitus, Type 1, Humans, Hypoglycemia, Risk Factors, Self Administration, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review